1. Discovery of new anti-depressants from structurally novel 5-HT3 receptor antagonists: design, synthesis and pharmacological evaluation of 3-ethoxyquinoxalin-2-carboxamides
- Author
-
Thangaraj Devadoss, Radhakrishnan Mahesh, Dilip Kumar Pandey, and Shvetank Bhatt
- Subjects
Agonist ,medicine.drug_class ,Hydrochloride ,Stereochemistry ,Clinical Biochemistry ,Guinea Pigs ,Drug Evaluation, Preclinical ,Pharmaceutical Science ,Myenteric Plexus ,Carboxamide ,Pharmacology ,Biochemistry ,Chemical synthesis ,5-HT3 receptor ,Piperazines ,chemistry.chemical_compound ,Structure-Activity Relationship ,Quinoxalines ,Drug Discovery ,medicine ,Animals ,Serotonin 5-HT3 Receptor Antagonists ,Molecular Biology ,biology ,Chemistry ,Organic Chemistry ,Antagonist ,Ligand (biochemistry) ,Receptor antagonist ,Amides ,Antidepressive Agents ,Drug Design ,biology.protein ,Molecular Medicine ,Receptors, Serotonin, 5-HT3 - Abstract
A novel series of 3-ethoxyquinoxalin-2-carboxamides were designed as per the pharmacophoric requirements of 5-HT(3) receptor antagonist using ligand-based approach. The desired carboxamides were synthesized from the key intermediate, 3-ethoxyquinoxalin-2-carboxylic acid by coupling with appropriate amines in the presence of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC·HCl) and 1-hydroxybenzotriazole (HOBt). The 5-HT(3) receptor antagonism was evaluated in longitudinal muscle myenteric plexus preparation from guinea pig ileum against 5-HT(3) agonist, 2-methy-5-HT, which was expressed in the form of pA(2) values. Compound 6h (3-ethoxyquinoxalin-2-yl)(4-methylpiperazin-1-yl)methanone was found to be the most active compound, which expressed a pA(2) value of 7.7. In forced swim test, the compounds with higher pA(2) value exhibited good anti-depressant-like activity and compounds with lower pA(2) value failed to show activity as compared to the vehicle-treated group.
- Published
- 2010